Grants/Funds Awarded
Ongoing Adu/Ojo (PIs) 2017-2022
- H3 Africa Kidney Disease Cohort Study Network; a 5-year NIH sponsored multi-center genomic research into kidney diseases in Africa.
Role: Site PI
Adu/Ojo (PIs) 2018-2023
- H3Africa Kidney Disease RENEWAL Study; a 5-year NIH sponsored multi-center genomic research into kidney diseases in Africa.
Role: Site PI
- R01HD071779 Awewura (PI) 07/15/12-08/30/23
Pharmokinetics of anti-tuberculosis and antiretroviral drugs in children
The goal of this study is to determine the pharmacokinetics of first line anti-tuberculosis and antiretroviral drugs in children. Role: Site PI
- 1R01HD103512-01 Paintsil (PI) 08/15/2020-06/30/21
Pediatric HIV Disclosure Intervention and Benefits Study (PhD-BS)—SANKOFA 2
5.Pharmacokinetics and Pharmacodynamics of Dolutegravir in children weighing 20kg and more living with HIV with or without TB; a 2-year NIH-sponsored collaborative research between University of Florida, USA, and Kwame Nkrumah University of Science & Technology. December 2020 and ongoing.
Position: Site PI
6.Will intravenous albumin reduce the mortality of children with oedematous malnutrition and shock? A 1-year pilot study between Child Health Africa and Kwame Nkrumah University of Science & Technology and University for Development Studies, Tamale. May 2021. Position: PI
Completed
R01HD074253 Paintsil (PI) 9/1/12-6/30/18 (NCE)
NICHD / NIH
A Bioecological Pediatric HIV disclosure Intervention in Ghana - SANKOFA
Goal is to provide information on a structured disclosure intervention that can be integrated into usual care in Ghana and other resource-limited settings to improve the welfare of HIV-infected children and their caregivers.
Role: Co-Investigator
U54HG006939 Adu/Ojo (PIs) 8/15/12-31/07/2017
The H3Africa Kidney Disease Research Network
The goal of this study is to assess the gene:environment interaction on the development of chronic kidney disease in people within the African community.
Role: Co-Investigator